Allergic rhinitis (AR) is a chronic inflammatory disease of nasal mucosa. Loss of function of Th17 cells and regulatory T (Treg) cells plays a role in the pathogenesis of AR. IL18, FOXP3, and IL13 are key genes in the development of AR. However, the genetic associations between IL18, FOXP3 and IL13 genes polymorphisms and AR risk were inconclusive yet.
A meta-analysis was performed by searching through Pubmed, EMBASE, web of science and CNKI databases. The ORs and 95%CIs were used to assess the genetic association between the allelic, dominant and recessive models of IL18, FOXP3 and IL13 genes polymorphisms and AR risk.
A total of 15 articles (6 for FOXP3, 5 for IL18, and 5 for IL13) were enrolled in the present study. No association was detected between the IL18 rs187238, rs1946518, rs360721, FOXP3 rs2232365, rs3761548 and IL13 rs1800925 polymorphisms and AR risk (p > 0.05). Significant associations were observed between the allelic (p = 0.001, OR 1.32, 95% CI 1.12–1.56), dominant (p = 0.005, OR 1.43, 95% CI 1.11–1.83) and recessive models (p = 0.01, OR 1.64, 95% CI 1.13, 2.40) of IL13 rs20541 and AR risk. Subgroup analysis based on ethnicity revealed that the IL13 rs20541 was significantly associated with AR risk in Asian population (allelic model: p = 0.009, OR 1.36, 95% CI 1.13–1.63, dominant model: p = 0.005, OR 1.43, 95% CI 1.11–1.83; recessive model: p = 0.01, OR 1.64, 95% CI 1.13–2.40).
IL13 rs20541 may contribute to the risk of AR in Asian population. To confirm these results, larger number of case–control study with more subjects is necessary in the future.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Plaut M, Valentine MD. Allergic Rhinitis. N Engl J Med. 2005;353:1934–44.
Bernstein DI, Schwartz G, Bernstein JA. Allergic rhinitis: mechanisms and treatment. Immunol allergy Clin N Am. 2016;36(2):261–78.
May JR, Dolen WK. Management of allergic rhinitis: a review for the community pharmacist. Clin Ther. 2017;39(12):2410–9.
Sinha B, Vibha X, Singla R, Chowdhury R. Allergic rhinitis: a neglected disease—a community based assessment among adults in Delhi. J Postgrad Med. 2015;61(3):169–75.
Dunlop J, Matsui E, Sharma HP. Allergic rhinitis: environmental determinants. Immunol Allergy Clin N Am. 2016;36(2):367–77.
Lee JH, Koh SH. Genetic role in allergic rhinitis. J Rhinol. 2010;17(1):7–12.
Gu ZW, Wang YX, Cao ZW. Neutralization of interleukin-9 ameliorates symptoms of allergic rhinitis by reducing Th2, Th9, and Th17 responses and increasing the Treg response in a murine model. Oncotarget. 2017;8(9):14314–24.
Xiao C, Li H, Li H, Cheng Z, Qin J, Zhou W, et al. The effect of specific immunotherapy on the regulation of Th1/Th2 cell ratio of the patients with allergic rhinitis in serum. J Clin Otorhinolaryngol. 2010;24(20):924–7.
Yu SQ. Content of CD4+CD25+ regulatory T cells in peripheral blood lymphocytes in patients with allergic rhinitis. J Clin Otorhinolaryngol Head Neck Surg. 2011;25(8):354–9.
Larsson K, Lindstedt M, Lundberg K, Dexlin L, Wingren C, Korsgren M, et al. CD4+ T cells have a key instructive role in educating dendritic cells in allergy. Int Arch Allergy Immunol. 2009;149(1):1–15.
Liu Y, Zeng M, Liu Z. Clinical relevance of Th17 response in allergic rhinitis: more evidence. Clin Exp Allergy. 2015;45(12):1875.
Ciprandi G, Filaci G, Fenoglio D. Th17 cells and allergic rhinitis: is there clinical relevance? Otolaryngol Head Neck Surg. 2010;143(4):604–5.
Lee SM, Gao BX, Dahl M, Calhoun K, Fang D. Decreased FOXP3 gene expression in the nasal secretions from patients with allergic rhinitis. Otolaryngol Head Neck Surg. 2009;140(2):197–201.
Zhang L, Zhang Y, Desrosiers M, Wang C, Zhao Y, Han D. Genetic association study of FOXP3 polymorphisms in allergic rhinitis in a Chinese population. Human Immunol. 2009;70(11):934.
Fodor E, Garaczi E, Hilda P, et al. The rs3761548 polymorphism of FOXP3 is a protective genetic factor against allergic rhinitis in the Hungarian female population. Human Immunol. 2011;72(10):930–4.
Zhang Y, Duan S, Wei X, Zhao Y, Zhao L, Zhang L. Association between polymorphisms in FOXP3 and EBI3 genes and the risk for development of allergic rhinitis in Chinese subjects. Hum Immunol. 2012;73(9):939–45.
Miller AL. The etiologies, pathophysiology, and alternative/complementary treatment of asthma. Altern Med Rev. 2001;6(1):20–47.
Huebner M, Kim DY, Ewart S, Karmaus W, Sadeghnejad A, Arshad SH. Patterns of GATA3 and IL13 gene polymorphisms associated with childhood rhinitis and atopy in a birth cohort. J Allergy Clin Immunol. 2008;121(2):408–14.
Llanes E, Quiralte J, López E. Analysis of polymorphisms in olive pollen allergy: IL13, IL4RA, IL5 and ADRB2 genes. Int Arch Allergy Immunol. 2009;148(3):228–38.
Wang M, Xing ZM, Lu C, Ma YX, Yu DL, Yan Z. A common IL-13 Arg130Gln single nucleotide polymorphism among Chinese atopy patients with allergic rhinitis. Hum Genet. 2003;113(5):387–90.
Bottema RWB, Nolte IM, Howard TD. Interleukin 13 and interleukin 4 receptor-α polymorphisms in rhinitis and asthma. Int Arch Allergy Immunol. 2010;153(3):259–67.
Wong CK, Ho CY, Ko FW, Chan CH, Ho AS, Hui DS, et al. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol. 2001;125(2):177–83.
Sebelova S, Izakovicova-Holla L, Stejskalova A, Schüller M, Znojil V, Vasku A. Interleukin-18 and its three gene polymorphisms relating to allergic rhinitis. J Hum Genet. 2007;52(2):152–8.
Tungtrongchitr A, Jumpasri J, Sookrung N, Visitsunthorn N, Tantilipikorn P, Piboonpocanan O, et al. Alteration of -656(G/T) and -607(C/A) polymorphisms in interleukin-18 (IL-18) gene in house dust mite-sensitive allergic rhinitis patients in Thailand. Genet Mol Res. 2017;16:3.
Ibrahim GH, Eltabbakh MT, Gomaa AHA, Mohamed EA. Interleukin-18 gene polymorphisms in Egyptian patients with allergic diseases. Am J Rhinol Allergy. 2012;26(5):385–9.
Holla LI, Hrdliková B, Schüller M, Buckova D, Kindlova D, Izakovic V, et al. Haplotype analysis of the interleukin-18 gene in Czech patients with allergic disorders. Human Immunol. 2010;71(6):597.
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Euro J Epidemiol. 2010;25(9):603–5.
Li ZL, Li YG, Lu JP, Chen SQ. Study on FOXP3 -924 polymorphisms in patients with allergic rhinitis. Anat Res. 2014;36(2):124–7.
Hassannia H, Abediankenari S, Ghaffari J. FOXP3 and TGFβgene polymorphisms in allergic rhinitis. Iran J Immunol. 2011;8(4):218–25.
Song QL. Study on the relationship between FOXP3 gene polymorphism and allergic rhinitis. Int J Immunol. 2016;39(2):139–41.
Kim JJ, Min JY, Lee JH. Polymorphisms in the IL-13 and IL-4 receptor alpha genes and allergic rhinitis. Eur Arch Otorhinolaryngol. 2007;264(4):395–9.
Micheal S, Minhas K, Ishaque M, Ahmed F, Ahmed A. IL-4 gene polymorphisms and their association with atopic asthma and allergic rhinitis in Pakistani patients. J Investig Allergol Clin Immunol. 2013;23(2):107–11.
Li YG, Liu ZW, Lu JP. Investigation into the polymorphism of interleukin-13 1112 C%3eT in allergic rhinitis patients. China Trop Med. 2012;12(1):67–9.
Lee HM, Park SA, Chung SW, Woo JS, Chae SW, Lee SH, et al. Interleukin-18/-607 gene polymorphism in allergic rhinitis. Int J Pediatr Otorhinolaryngol. 2006;70(6):1085–8.
KleinJan A, Willart M, Van Nimwegen M, Leman K, Hoogsteden HC, Hendriks RW, et al. United airways: circulating Th2 effector cells in an allergic rhinitis model are responsible for promoting lower airways inflammation. Clin Exp Allergy. 2010;40(3):494–504.
Ciprandi G. Symptom severity and allergen-specific IgE in allergic rhinitis. Iran J Allergy Asthma Immunol. 2017;16(1):79–81.
Devos FC, Pollaris L, Cremer J, Seys S, Hoshino T, Ceuppens J, et al. IL-13 is a central mediator of chemical-induced airway hyperreactivity in mice. PLoS ONE. 2017;12(7):e0180690.
Barlow JL, Bellosi A, Hardman CS, Drynan LF, Wong SH, Cruickshank JP, et al. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J Allergy Clin Immunol. 2011;129(1):191.e1–4–8.e1–4.
Yosri H, Elkashef WF, Said E, Gameil NM. Crocin modulates IL-4/IL-13 signaling and ameliorates experimentally induced allergic airway asthma in a murine model. Int Immunopharmacol. 2017;50:305–12.
Guo LY, Li JH, Paul WE. Probabilistic regulation in TH2 Cells accounts for monoallelic expression of IL-4 and IL-13. Immunity. 2005;23(1):89–99.
Defrance T. Interleukin 13 is a B cell stimulating factor. J Exp Med. 1994;179(1):135–43.
Ngoc PL, Ngoc LP, Gold DR, Tzianabos AO, Weiss ST, Celedón JC. Cytokines, allergy, and asthma. Curr Opin Allergy Clin Immunol. 2005;5(2):161–6.
Alasandagutti ML, Ansari MSS, Sagurthi SR, Valluri V, Gaddam S. Role of IL-13 genetic variants in signalling of asthma. Inflammation. 2017;40(2):1–12.
Gleń J, Trzeciak M, Sobjanek M, Bandurski T, Wilkowska A, Nedoszytko B, et al. Interleukin-13 promoter gene polymorphism -1112 C/T is associated with Atopic dermatitis in Polish patients. Acta Dermatovenerol Croat. 2012;20(4):231–8.
Hummelshoj T, Bodtger U, Datta P, Malling HJ, Oturai A, Poulsen LK, et al. Association between an interleukin-13 promoter polymorphism and atopy. Int J Immunogenet. 2003;30(5):355–9.
Ying XJ, Zhao SW, Wang GL, Tzianabos AO, Weiss ST, Celedón JC. Association of interleukin-13 SNP rs20541 with allergic rhinitis risk: a meta-analysis. Gene. 2013;521(2):222–6.
Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol. 2006;24(1):209–26.
Wang K, Zhu TJ, Wang HJ, Yang JX, Du SS, Dong GY, et al. Adoptive transfers of CD4+ CD25+ Tregs raise FOXP3 expression and alleviate mouse enteritis. Biomed Res Int. 2018;2018(2):1–9.
Solomou EE, Rezvani K, Mielke S, Malide D, Visconte V, Keyvanfer K, et al. FOXP3-positive regulatory T-cells in acquired aplastic anemia. Blood. 2006;108(11):2248.
Cui G, Zhang Y, Gong Z, Zhang JZ, Zang YQ. Induction of CD4+CD25+FOXP3+ regulatory T cell response by glatiramer acetate in type 1 diabetes. Cell Res. 2009;19(5):574–83.
Choi JM, Shin JH, Sohn MH. Cell-permeable FOXP3 protein alleviates autoimmune disease associated with inflammatory bowel disease and allergic airway inflammation. Proc Natl Acad Sci USA. 2010;107(50):21943–21943.
Lee JH, Yu HH, Wang LC, Yang YH, Lin YT, Chiang BL. The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma. Clin Exp Immunol. 2007;148(1):53–63.
Ban Y, Tozaki T, Tobe T, Ban Y, Jacobson EM, Concepcion ES, et al. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J Autoimmun. 2007;28(4):201–7.
The present study was funded by the National Natural Science Foundation of China (Grant nos. 81873780, 61702054); Hunan Natural Science Foundation Youth Program (2019JJ50697, 2018JJ3568); The Changsha Outstanding Innovative Young People Training Scheme (kq1905047, kq1905045); The Foundation of the Education Department of Hunan Province (16A027, 19A058); The Foundation of Health and Family Planning Commission of Hunan Province (20201918); The Application Characteristic Discipline of Hunan Province; The Hunan Key Laboratory Cultivation Base of the Research and Development of Novel Pharmaceutical Preparations (No. 2016TP1029); The clinical research center of neurodegenerative diseases in Hunan province (2018SK4002); The Hunan Provincial Innovation Platform and Talents Program (No. 2018RS3105); The Hunan provincial science and technology department and Hunan provincial health and family planning commission (Grant No.85); The Natural science foundation of Hunan province (Grant No.1); The Key project of Hunan provincial commission of health and family planning (Grant No.144); The Hunan province science and technology major project (Grant No.158); Hunan Provincial Science and Technology Department Clinical Medical Technology Innovation Guide Project(2018SK51711).
Conflict of interest
The authors declare that they have no competing interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Responsible Editor: John Di Battista.
About this article
Cite this article
Tang, L., Chen, Y., Xiang, Q. et al. The association between IL18, FOXP3 and IL13 genes polymorphisms and risk of allergic rhinitis: a meta-analysis. Inflamm. Res. (2020). https://doi.org/10.1007/s00011-020-01368-4
- Allergic rhinitis